Indicator | First Year | Performance in the First Year | Performance, 2014 | Performance, 2018 |
---|---|---|---|---|
Influenza vaccine, asthma | 2003 | 23.1% | 41.7% | 35.3% |
Asthma medication ratio > 0.5 | 2014 | 67.4% | 70.9% | |
Spirometry in COPD | 2013 | 52.0% | 57.9% | 75.5% |
Mammography | 2003 | 51.6% | 69.3% | 72.5% |
Colorectal screening | 2003 | 11.8% | 58.3% | 64.8% |
PAP smear, 3y | 2014 | 48.1% | 51.5% | |
Influenza vaccine >65y | 2003 | 43.9% | 63.4% | 60.4% |
Pneumococcal vaccine | 2008 | 70.9% | 76.6% | 77.5% |
Periodic testing for Hb A1c in diabetes | 2003 | 85.2% | 90.0% | 90.7% |
Hb A1c - good control | 2003 | 42.0% | 66.4% | 70.8% |
Ab A1c > 9% | 2003 | 17.8% | 11.6% | 9.6% |
LDL in diabetes | 2003 | 83.5% | 90.8% | 90.9% |
LDL < 100 in diabetes | 2003 | 39.2% | 63.1% | 66.0% |
Eye exam in diabetes | 2003 | 56.5% | 75.0% | 72.5% |
Microalbumin tested | 2003 | 38.8% | 78.6% | 81.2% |
Influenza vaccine, diabetes | 2003 | 38.6% | 61.6% | 59.8% |
BP documented in diabetes | 2003 | 38.7% | 90.0% | 90.7% |
BMI documented in diabetes | 2008 | 81.8% | 88.0% | 84.8% |
Pneumococcal vaccine, diabetes | 2008 | 76.3% | 81.9% | 84.4% |
BP controlled in diabetes | 2011 | 82.3% | 83.7% | 83.0% |
Diabetic nephropathy | 2011 | 31.5% | 30.5% | 32.1% |
Cholesterol tested, 35-54y | 2003 | 60.2% | 86.1% | 88.1% |
Cholesterol tested, 55-74y | 2003 | 63.2% | 76.7% | 75.3% |
LDL controlled | 2013 | 83.5% | 83.9% | 84.2% |
LDL < 100 in high risk patients | 2013 | 27.8% | 30.8% | 34.4% |
BP documented, 20-54y | 2003 | 21.8% | 91.2% | 92.5% |
BP documented, 55-74y | 2003 | 30.6% | 81.9% | 80.8% |
Body-mass index documented | 2008 | 56.5% | 88.2% | 89.6% |
Smoking status documented | 2011 | 79.4% | 87.9% | 90.7% |
Statins in ischemic heart disease | 2014 | 82.2% | 82.4% | |
Hemoglobin test in infants | 2008 | 71.7% | 85.3% | 88.3% |
Anemia in infants | 2014 | 8.1% | 8.2% | |
Benzodiazepines, elderly | 2011 | 4.9% | 5.2% | 4.8% |
Tertiary prevention, hip fracture | 2015 | 25.5% | 25.5% | 28.1% |
Antibiotics DDD per 1000 | 2014 | 20.8 | 19.1 | |
Use of cephalosporins/quinolones | 2014 | 22.1% | 25.2% | |
Community psychiatrist care following psychiatric admission | 2015 | 32.5% | 37.3% |